We could not find any results for:
Make sure your spelling is correct or try broadening your search.
This company believes that the only viable way to produce a safe supply of street drugs is to develop biosynthetic versions of these substances to be manufactured domestically in a regulated To...
Pharmagen Appoints Industry Veteran Russell Skibsted as Chief Financial Officer ("CFO ") PR Newswire SILVER SPRING, Md., June 11, 2014 SILVER SPRING, Md., June 11, 2014 /PRNewswire/...
Pharmagen Appoints Additional Members to its Board of Directors PR Newswire SILVER SPRING, Md., May 29, 2014 SILVER SPRING, Md., May 29, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPink: PHRX) (the...
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales PR Newswire SILVER SPRING, Md., May 6, 2014 SILVER SPRING, Md., May 6, 2014 /PRNewswire/ -- Pharmagen, Inc. (OTCPINK: PHRX...
Boyd Relac joins the Pharmagen Executive Team as Chief Operating Officer ("COO") PR Newswire SILVER SPRING, Md., April 29, 2014 SILVER SPRING, Md., April 29, 2014 /PRNewswire/...
Pharmagen Completes Bridge Financing to Support Consolidation and Capital Restructure Plan PR Newswire SILVER SPRING, Md., April 22, 2014 SILVER SPRING, Md., April 22, 2014 /PRNewswire/...
Pharmagen Partners with Bagel Boy Equity Group II, LLC and prepares to Launch its Industry Consolidation Strategy PR Newswire SILVER SPRING, Md., Dec. 17, 2013 SILVER SPRING, Md., Dec. 17, 2013...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 5050 | 1.0E-6 | CS |
4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 1024420 | 1.0E-6 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 561784 | 1.0E-6 | CS |
26 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 329233 | 1.0E-6 | CS |
52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 233565 | 1.0E-6 | CS |
156 | 0 | 0 | 1.0E-6 | 0.0003 | 1.0E-6 | 74786 | 7.35E-6 | CS |
260 | -0.000699 | -99.8571428571 | 0.0007 | 0.0039 | 1.0E-6 | 234502 | 0.00057593 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions